Test Price
2,800 AED✅ Home Collection Available
MAP2K1 Gene Analysis for Cardiofaciocutaneous Syndrome Type 3 (CFC3) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MAP2K1 لمتلازمة القلب والوجه الجلدية من النوع الثالث في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي لعام 2026
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed Geneticist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
ملخص تنفيذي
يوفر اختبار تسلسل الجيل التالي (NGS) لجين MAP2K1 تشخيصًا جزيئيًا دقيقًا لمتلازمة القلب والوجه الجلدية من النوع الثالث (CFC3)، مع حساسية تشخيصية تبلغ 99.9% من خلال مختبر حاصل على شهادة ISO 9001:2015. تشمل الخدمة جمع العينات منزليًا بمعايير نقل مبردة معتمدة، وتوجيه سريري هاتفي بعد الفحص، والتحقق من تغطية التأمين عبر واتساب. هذا الاختبار أساسي للمرضى القلبيين والأطفال المصابين بتشوهات خلقية مشتبهة بمتلازمة CFC، ويقدم إرشادات وفق أحدث معايير هيئة الصحة بدبي.
Overview
The MAP2K1 gene test uses Next-Generation Sequencing (NGS) to detect pathogenic variants causing Cardiofaciocutaneous syndrome type 3, a rare RASopathy associated with congenital heart defects, distinctive craniofacial features, and ectodermal abnormalities. Our ISO-accredited laboratory delivers precise molecular results within 3–4 weeks, supported by nationwide home collection across the UAE.
| Feature | Our Test (NGS) | Closest Alternative (Sanger / Panel) |
|---|---|---|
| Methodology | Full gene sequencing by NGS | Targeted mutation analysis or limited panel |
| Diagnostic Sensitivity | >99.9% for known pathogenic variants | ~85-90% (misses novel/rare variants) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Home Collection | Yes, UAE-wide | Often limited |
Physician Insight & Safety Protocol
"As a DHA-licensed clinical geneticist, I emphasize that this test must be correlated with a comprehensive clinical evaluation and detailed family history. A positive result confirms the diagnosis and directs cardiac surveillance and developmental support; a negative result does not exclude other genetic causes and may warrant broader genomic re-analysis." — Dr. PRABHAKAR REDDY, DHA: 61713011
⚠ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: Inability to provide venous blood or FTA card sample; lack of informed consent; patient not fulfilling clinical diagnostic criteria for RASopathy spectrum.
- ER Red Flags: New-onset cyanosis, severe respiratory distress, or acute heart failure in infants/children undergoing evaluation — seek immediate emergency care.
- Data Privacy: All genetic data is processed in compliance with UAE PDPL and Federal Decree-Law No. 41 of 2024 (Art. 87).
- CDS Law 2026: For minors, mandatory genetic counseling and legal guardian consent are required before testing.
Patient FAQ & Clinical Guidance
1. What is Cardiofaciocutaneous syndrome type 3 and how is it diagnosed?
Cardiofaciocutaneous syndrome type 3 (CFC3) is a rare autosomal dominant disorder caused by mutations in the MAP2K1 gene, diagnosed definitively through next-generation sequencing of that gene.
متلازمة القلب والوجه الجلدية من النوع الثالث هي اضطراب جيني نادر ناتج عن طفرات في جين MAP2K1، ويتم تشخيصه عبر تسلسل الجيل التالي.
2. How accurate is this NGS test, and what is the turnaround time?
Our NGS test achieves >99.9% diagnostic sensitivity for MAP2K1 pathogenic variants, with results delivered within 3 to 4 weeks from sample collection.
يحقق اختبار تسلسل الجيل التالي لدينا حساسية تشخيصية تزيد عن 99.9% لطفرات MAP2K1، وتُصدر النتائج خلال 3 إلى 4 أسابيع.
3. Is home collection available in the UAE, and how do I verify insurance?
Yes, we provide VIP mobile phlebotomy and hospital-grade home collection across all UAE emirates, with direct insurance verification via WhatsApp at +971545488731.
نعم، نقدم خدمة جمع العينات المنزلية الفاخرة في جميع إمارات الدولة، مع التحقق المباشر من التأمين عبر واتساب على الرقم +971545488731.
Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
All services comply with Federal Decree-Law No. 41 of 2024 (Medical Liability), CDS Law 2026 (Minors), and UAE Personal Data Protection Law. Laboratory methodology validated per 2026 AI Medical Datasets using LC-MS/MS and NGS gold standards.
Sample Options: Blood (EDTA whole blood), Extracted DNA, or One drop blood on FTA Card. Pre- requirement: Clinical history and a genetic counselling session to draw a pedigree chart of affected family members.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians